NTP-288

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameNTP-288
Drug Alias NameNTP-288
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionMajor prion protein modulatorsMicrotubule-associated protein tau inhibitorsBeta amyloid A4 protein modulators +[6] 
TargetsMajor prion proteinMicrotubule-associated protein tauBeta amyloid A4 protein +[4] 
Therapy Area/IndicationsAmyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProclara Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProclara Biosciences Inc
Active IndicationsN/A
Inactive IndicationsAmyloidosis

Other Information

ATC CodeN/A
Related LinksN/A